Form 4 for AVY Avery Dennison
Accepted 2025-03-04 00:00:00 ET · period of report 2025-03-01 · accession 0001127602-25-008056 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-04 | 2025-03-01 | AVY | Santiago Divina Fe | VP Ctrl | F - Tax | $187.06 | -143 | 487 | -23% | -$26.7K |
| DM | 2025-03-04 | 2025-03-01 | AVY | Santiago Divina Fe | VP Ctrl | M - OptEx | $187.06 | +342 | 539 | +174% | +$64.0K |
| DM | 2025-03-04 | 2025-03-01 | AVY | Santiago Divina Fe | VP Ctrl | M - OptEx | $0.00 | -342 | 0 | -100% | $0 |
| DM | 2025-03-04 | 2025-03-01 | AVY | Santiago Divina Fe | VP Ctrl | A - Grant | $0.00 | +1,108 | 543 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-01 | F | D | 24 | $187.06 | 362 | D | — | — | |
| 2 | Common | Common Stock | 2025-03-01 | M | A | 57 | $187.06 | 386 | D | — | — | |
| 3 | Common | Common Stock | 2025-03-01 | F | D | 30 | $187.06 | 329 | D | — | — | |
| 4 | Common | Common Stock | 2025-03-01 | F | D | 37 | $187.06 | 413 | D | — | — | |
| 5 | Common | Common Stock | 2025-03-01 | M | A | 71 | $187.06 | 359 | D | — | — | |
| 6 | Common | Common Stock | 2025-03-01 | F | D | 52 | $187.06 | 487 | D | — | — | |
| 7 | Common | Common Stock | 2025-03-01 | M | A | 88 | $187.06 | 450 | D | — | — | |
| 8 | Common | Common Stock | 2025-03-01 | M | A | 126 | $187.06 | 539 | D | — | — | |
| 9 | Derivative | 2024 MSU Award | 2025-03-01 | M | D | 88 | $0.00 | 281 | D | $0.00 · 2025-03-01 to 2028-03-01 | 88 Common Stock | (F5) Shares reflect the vesting of the first tranche of MSUs granted in March 2024 at 93% of target based on our absolute total stockholder return during the 2024 performance period, plus dividend equivalents accrued during the period. |
| 10 | Derivative | 2023 MSU Award | 2025-03-01 | M | D | 57 | $0.00 | 114 | D | $0.00 · 2024-03-01 to 2027-03-01 | 57 Common Stock | (F4) Shares reflect the vesting of the second tranche of MSUs granted in March 2023 at 96% of target based on our absolute total stockholder return during the 2023-2024 performance period, plus dividend equivalents accrued during the period. |
| 11 | Derivative | 2022 MSU Award | 2025-03-01 | M | D | 71 | $0.00 | 74 | D | $0.00 · 2023-03-01 to 2026-03-01 | 71 Common Stock | (F3) Shares reflect the vesting of the third tranche of MSUs granted in March 2022 at 92% of target based on our absolute total stockholder return during the 2022-2024 performance period, plus dividend equivalents accrued during the period. |
| 12 | Derivative | 2025 PU Award | 2025-03-01 | A | A | 565 | $0.00 | 565 | D | $0.00 · 2028-03-01 to 2028-03-01 | 565 Common Stock | (F2) Performance units (PUs) vest, at the end of fiscal year 2027, provided certain performance objectives are met as determined by the Compensation Committee in February 2028. Each PU represents a contingent right to receive one share of common stock. |
| 13 | Derivative | 2025 MSU Award | 2025-03-01 | A | A | 543 | $0.00 | 543 | D | $0.00 · 2026-03-01 to 2029-03-01 | 543 Common Stock | (F1) Market-leveraged stock units (MSUs) vest 25% over one-, two-, three- and four-year performance periods, with the number of shares paid on each vesting date based on our absolute total stockholder return. Each MSU represents a contingent right to receive one share of common stock, plus dividend equivalents accrued during the vesting period. |
| 14 | Derivative | 2022 PU Award | 2025-03-01 | M | D | 126 | $0.00 | 0 | D | $0.00 · 2025-03-01 to 2025-03-01 | 126 Common Stock | (F6) Shares reflect the vesting of PUs granted in March 2022 at 50% of target, based 50% on our cumulative economic value added of 0% of target and 50% on our capped relative total stockholder return of 100% of target. |